Page last updated: 2024-11-01

ondansetron and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ondansetron has been researched along with Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bakırcı, Ş1
Sağsöz, N1
Devrim, T1
Şahin, Y1
Bulanık, M1
Gözüyukarı, H1

Other Studies

1 other study available for ondansetron and Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous

ArticleYear
Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:12

    Topics: Animals; Cabergoline; Dopamine Agonists; Endothelial Cells; Female; Humans; Ondansetron; Ovarian Hyp

2022